Data presented at Kidney Week 2025 showed single subcutaneous administration of megalin-STRIKERs resulted in increased excretion of disease-related solute levels lasting for at least 2 months ...
He developed extracorporeal membrane oxygenation, or ECMO, a treatment that can sustain patients whose hearts and lungs are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback